Treatment of pediatric localized scleroderma: Results of a survey of North American pediatric rheumatologists

Journal of Rheumatology

Volumn 37, Issue 1, 2010, Pages 175-181

  Li, Suzanne C ^a   Feldman, Brian M ^a,b   Higgins, Gloria C ^a,c   Haines, Kathleen A ^a   Punaro, Marilynn G ^a,d   O'Neil, Kathleen M ^a,e  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Drug therapy; Localized scleroderma; Pediatrics; Survey

Indexed keywords

AZATHIOPRINE; CALCIPOTRIOL; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMATINIB; IMIQUIMOD; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLAMINE; PIMECROLIMUS; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ARTICLE; CANADA; CHILD; FACE; FEMALE; HUMAN; JOINT; LOCALIZED SCLERODERMA; MAJOR CLINICAL STUDY; MORBIDITY; NORTH AMERICA; PEDIATRICS; POPULATION; PRIORITY JOURNAL; RHEUMATOLOGY; TREATMENT DURATION; UNITED STATES; VIGNETTE;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTIRHEUMATIC AGENTS; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; HUMANS; METHOTREXATE; OUTCOME ASSESSMENT (HEALTH CARE); PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; RHEUMATOLOGY; SCLERODERMA, LOCALIZED; TREATMENT OUTCOME;

EID: 73649128521     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090708     Document Type: Article

References (27)

1. Uziel Y, Krafchik B, Silverman E, Thorner P, Laxer R. Localized scleroderma in childhood: a report of 30 cases. Semin Arthritis Rheum 1994;23:328-40.
2. Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 2005;52:2873-81.
3. Peterson L, Nelson A, Su W, Mason T, O'Fallon W, Gabriel S. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997;24:73-80.
4. Seyger M, van den Hoogen F, de Boo T, de Jong E. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol 1998;39:220-5.
5. Uziel Y, Feldman B, Krafchik B, Yeung R, Laxer R. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 2000;136:91-5.
6. Fitch P, Rettig P, Burnham J, Finkel T, Yan A, Akin E, et al. Treatment of pediatric localized scleroderma with methotrexate. J Rheumatol 2006;33:609-14.
7. Weibel L, Sampaio M, Visentin M, Howell K, Woo P, Harper J. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol 2006;155:1013-20.
8. Elst E, Van Suijlekom-Smit L, Oranje A. Treatment of linear scleroderma with oral 1,25 dihydroxyvitamin D3 (calcitriol) in seven children. Pediatr Dermatol 1999;19:53-8.
9. Dytoc M, Ting P, Man J, Sawyer D, Florillo L. First case series on the use of imiquimod for morphoea. Br J Dermatol 2004;153:815-20.
10. Mancuso G, Berdondini R. Topical tacrolimus in the treatment of localized scleroderma. Eur J Dermatol 2003;13:590-2.
11. Laxer R, Zulian F. Localized scleroderma. Curr Opin Rheumatol 2006;18:606-13.
12. Chung L, Lin J, Furst D, Fiorentino D. Systemic and localized scleroderma. Clin Dermatol 2006;24:374-92.
13. Zulian F. Systemic sclerosis and Localized Scleroderma in Childhood. Rheum Dis Clin N Am 2008;34:239-55.
14. Dytoc M, Kossintseva I, Ting P. First case series on the use of calcipotriol-betamethasone diproprionate for morphoea. Br J Dermatol 2007;157:615-8.
15. Kreuter A, Hyunn J, Stücker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006;54:440-7.
16. Stege H, Berneburg M, Humke S, Klammer M, Grewe M, Grether-Beck S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997;36:938-44.
17. Kerscher M, Volkenandt M, Gruss C, et al. Low-dose UVA1 phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998;38:21-6.
18. Joly P, Bamberger N, Crickx B, Belaich S. Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol 1994;130:664-5.
19. Kreuter A, Gambichler T, Breuckmann F, Rotterdam S, Freitag M, Stuecker M, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol 2005;141:847-52.
20. Liu P, Uziel Y, Silverman E, Krafchik B, Laxer R. Localized scleroderma: imaging features. Pediatr Radiol 1994;24:207-9.
21. Zannin M, Martini G, Athreya B, Russo R, Higgins G, Vittadello F, et al. Ocular involvement in children with localised scleroderma: a multi-centre study. Br J Ophthalmol 2007;91:1311-4.
22. Wallace C, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290-4.
23. Oen K, Malleson P, Cabral D, Rosenberg A, Petty R, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002;29:1989-99.
24. Flato B, Lien G, Smerdel A, Vinje O, Dale K, Johnston V, et al. Prognostic factors in juvenile rheumatoid arthritis: a case-controlled study revealing early predictors and outcome after 14.9 years. J Rheumatol 2003;30:386-93.
25. Christianson H, Dorsey C, O'Leary P, Kierland R. Localized scleroderma: a clinical study of two hundred thirty-five cases. Arch Dermatol 1956;74:629-39.
26. Krafchik B. Localized cutaneous scleroderma. Semin Dermatol 1992;11:65-72.
27. Veloski J, Tai S, Evans A, Nash D. Clinical vignette-based surveys: a tool for assessing physician practice variation. Am J Med Qual 2005;20:151-7.